Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2021 16:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference

SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
May 11, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Reports First Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
March 22, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis

SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,...
March 11, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,...
March 10, 2021 16:30 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Report Promising Preclinical Studies Supporting its Pipeline of Immunotherapy Platforms at AACR

Tumor model data shows potential of CCR4 antagonist to alter immunosuppressive tumor microenvironment to improve CAR T-cell therapy in solid tumorsSmall-molecule HPK1 inhibitors enhance antitumor...
March 03, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Participate in Two Investor Conferences in March

SOUTH SAN FRANCISCO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering,...
February 19, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
January 05, 2021 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
November 23, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...
November 16, 2020 08:00 ET | Source: RAPT Therapeutics, Inc.

RAPT Therapeutics Reports Third Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing...